InnovaTivE in situ 4D biopriNTing for regenerAtion of CoLorEctal mucosa and submucosa

PROJECt

TENTACLE pioneers in-situ 4D bioprinting to advance minimally invasive surgery, reducing patient trauma and improving care

Strategy

The project aims to offer a less invasive alternative for treating colorectal diseases by integrating 4D bioprinting into endoscopic procedures

RESULTS

Discover how TENTACLE’s innovative approach is shaping the future of precision medicine and redefining surgical standards

*

Duration

48 months

*

Partners

10

*

EU Contribution

7.555.750,00

About the project

TENTACLE pioneers a radically new way to treat colorectal diseases thanks to an innovative bioprinting strategy, marking a new chapter in regenerative medicine thanks to a cutting-edge use of biomedical engineering.

Find out more

Latest News & Events

2105, 2025

TENTACLE presented at TERMIS EU 2025: pioneering 4D bioprinting for colorectal regeneration

Sara Attanà2025-05-21T16:41:34+02:0021 May 2025|Categories: Article, Event, News|

20th May 2025 | Freiburg, Germany At the TERMIS EU [...]

TENTACLE Kick-off Meeting: 4D bioprinting for low impact-surgery

Sara Attanà2025-05-21T16:39:43+02:0021 January 2025|Categories: News, Technical Meeting|

20th-21st January 2025 | Würzburg, Germany TENTACLE is an [...]

*our TEAM

The excellence in their respective fields of expertise and their complementarity has been the underlying principle used to build TENTACLE consortium.

The consortium involves 10 partners including 5 topquality academic institutions.

Find out more

*Contact us

PROJECT COORDINATOR

Jürgen Groll

SCIENTIFIC COORDINATOR

Giovanni Vozzi

PROJECT MANAGER & DISSEMINATION MANAGER

Isella Vicini

InnovaTivE in situ 4D biopriNTing for regenerAtion of CoLorEctal mucosa and submucosa